Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
It's one of the holiest and most somber days in the Christian calendar as followers remember the execution of Jesus. This stained glass window by J & J King of Norwich depicts the crucifixion of Jesus ...
A new graphic novel both celebrates and demystifies the colorful frontier icon, while also correcting some of her taller tales. By Michael Wallis Lola Lafon’s book “When You Listen to This Song” is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback